Back to Newsroom
Back to Newsroom

AGNC, NWSA, OXGN and LXRX added to NASDAQ Active Stock Watch List at GSR

Tuesday, 12 November 2013 09:27 AM

Topic:

New York, NY - (ACCESSWIRE) - 11/12/2013 - Growing Stock Report initiates its NASDAQ Active Stock Watch List adding American Capital Agency Corp. (NASDAQ:AGNC), News Corporation (NASDAQ:NWSA), OXiGENE, Inc. (NASDAQ:OXGN) and Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) 

American Capital Agency Corp. (NASDAQ:AGNC) a company that operates as a real estate investment trust closed down in its previous session (-1.73%) on 9,298,447 shares traded after American Capital Agency Corp. announced that Gary Kain, President and Chief Investment Officer, is scheduled to make a presentation at the Bank of America Merrill Lynch 2013 Banking and Financial Services Conference today, November 12, 2013 in New York City. American Capital Agency Corp. (NASDAQ:AGNC) is currently down (-38.64%) from its recent 52-week high, which has prompted Growing Stock Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll. 

To find out what other Investors are saying about American Capital Agency Corp. (NASDAQ:AGNC)

Click Here: http://www.growingstockreport.com/Survey.aspx?stock=AGNC&SubId=AW 

News Corporation (NASDAQ:NWSA) a media and information services company that focuses on creating and distributing authoritative and engaging content to consumers and businesses worldwide closed down in its previous session (-1.02%) on 5,392,283 shares traded after the publishing company posted sales that missed analyst forecasts, sparking investor concern about its legacy print business. News Corporation (NASDAQ:NWSA) is currently down (-2.86%) from its recent 52-week high, which has prompted Growing Stock Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll. 

To find out what other Investors are saying about News Corporation (NASDAQ:NWSA)

Click Here: http://www.growingstockreport.com/Survey.aspx?stock=NWSA&SubId=AW 

OXiGENE, Inc. (NASDAQ:OXGN) a clinical-stage biopharmaceutical company that develops therapeutics primarily to treat cancer closed down in its previous session (-4.63%) on 456,194 shares traded as OXiGENE, Inc. will report third quarter 2013 results on todayNovember 12, 2013. OXiGENE, Inc. (NASDAQ:OXGN) is currently down (-50.33%) from its recent 52-week high which has prompted Growing Stock Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll. 

To find out what other Investors are saying about OXiGENE, Inc. (NASDAQ:OXGN)

Click Here: http://www.growingstockreport.com/Survey.aspx?stock=OXGN&SubId=AW 

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) a biopharmaceutical company that focuses on the discovery and development of treatments for human disease closed down in its previous session (-3.78%) on 561,980 shares traded after Lexicon Pharmaceuticals, Inc. announced that Lexicon management will present at the Credit Suisse Healthcare Conference on Wednesday, November 13, at 11:30 AM MT in Scottsdale, Arizona. Lexicon management will provide an overview of Lexicon's clinical development programs and milestones. Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) is currently down (-28.3%) from its recent 52-week high, which has prompted Growing Stock Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll. 

To find out what other Investors are saying about Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX)

Click Here: http://www.growingstockreport.com/Survey.aspx?stock=LXRX&SubId=AW 

GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.
Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.GrowingStockReport.com 

Disclosure: GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures. 

Contact Info:
Growing Stock Report
[email protected]
Topic:
Back to newsroom
Back to Newsroom
Share by: